ST Innovative Diagnostics
Monitoring Malignancies trough a Simple Blood Test
StartupST Innovative Diagnostics is a Be'er Ya'akov-based startup in the Health Tech & Life Sciences sector, established in 2022. Monitoring Malignancies trough a Simple Blood Test. The company has raised a total of $70K across 1 funding round, currently at the Seed stage. ST Innovative Diagnostics was founded by Esther Rabizadeh. The company has 1-10 employees. Core technologies: Biologicals, Molecules, Cells.
With $70K in total funding, ST Innovative Diagnostics is a Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2B/B2B2C business model. Product stage: Clinical Trial. The company holds 1 patent.
- StageSeed
- ProductClinical Trial
- ModelB2B, B2B2C
- Employees1-10
- HQBe'er Ya'akov
- DistrictCenter District
- Last Round$70K
Esther RabizadehChief Science Officer
1 article covered by sources including journals.plos.org.
What does ST Innovative Diagnostics do?
ST Innovative Diagnostics developed a novel blood-based malignancy monitoring test, based on research from Rabin Medical Center and Tel Aviv University. The company's proprietary technology & kit, measures Fibrinogen Like Protein 2 (FGL2) activity in platelets, enabling non-invasive disease monitoring and relapse prediction across multiple malignancies. POC Clinical studies have shown high correlation with PET/CT imaging in Non-Hodgkin's Lymphoma, Prostate Cancer, and Cutaneous T-Cell Lymphoma. The technology shows promise for early detection of treatment resistance in NHL patients, facilitating timely transition to second-line therapies and preventing T-cell exhaustion and is planned to expand to solid tumor monitoring & diagnosis, including Metastatic Colorectal and Pancreatic Cancers.
How much funding has ST Innovative Diagnostics raised?
ST Innovative Diagnostics has raised $70K in total funding across 1 rounds. The company is currently at the Seed stage.
Who founded ST Innovative Diagnostics ?
ST Innovative Diagnostics was founded in 2022 by Esther Rabizadeh (Chief Science Officer ).
What sector is ST Innovative Diagnostics in?
ST Innovative Diagnostics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Test Diagnostics & Screening, with core technologies in Biologicals, Molecules, Cells. Target customers: Healthcare & Life Sciences, Medical Devices Industry, Medical Equipment, Healthcare, Patients, Laboratories, Insurance Companies, Providers.
Where is ST Innovative Diagnostics located?
ST Innovative Diagnostics is based in Simtat HaAnkor 12, Be'er Ya'akov, Israel, Center District.